Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$1.22 - $4.83 $2,196 - $8,694
1,800 New
1,800 $0
Q1 2022

Apr 14, 2022

SELL
$3.58 - $4.98 $11,098 - $15,438
-3,100 Reduced 96.88%
100 $0
Q3 2021

Oct 26, 2021

BUY
$5.87 - $7.85 $11,740 - $15,700
2,000 Added 166.67%
3,200 $0
Q2 2021

Jul 19, 2021

SELL
$6.69 - $9.0 $2,007 - $2,700
-300 Reduced 20.0%
1,200 $0
Q1 2021

Apr 26, 2021

SELL
$8.26 - $11.4 $80,122 - $110,580
-9,700 Reduced 86.61%
1,500 $0
Q4 2020

Jan 21, 2021

BUY
$8.21 - $18.59 $89,489 - $202,631
10,900 Added 3633.33%
11,200 $4,000
Q3 2020

Oct 27, 2020

SELL
$11.33 - $19.81 $1,133 - $1,980
-100 Reduced 25.0%
300 $1,000
Q2 2020

Jul 22, 2020

BUY
$4.2 - $15.45 $1,680 - $6,180
400 New
400 $1,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.57B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.